XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE

The following table summarizes the amount of share-based compensation expense by line item on the statements of operations:

 

(in thousands)  2023   2022   2023   2022 
Share-based compensation expense  Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
(in thousands)  2023   2022   2023   2022 
Research and development expense  $2,194   $1,831   $4,438   $5,681 
Sales, marketing, general and administrative expense   2,497    2,250    7,068    6,254 
Total Share-based compensation expense  $4,691   $4,081   $11,506   $11,935 
SCHEDULE OF VALUATION ASSUMPTIONS FOR WEIGHTED-AVERAGE GRANT

The following table summarizes shares, weighted-average exercise price, weighted-average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of September 30, 2023:

 

           Weighted-     
       Weighted-   Average     
       Average   Remaining   Aggregate 
      Exercise   Contractual   Intrinsic 
Options  Shares   Price   Term (years)   Value 
Outstanding as of September 30, 2023   752,000   $1.35    4.9   $746,000 
                     
Exercisable as of September 30, 2023   752,000   $1.35    4.9   $746,000 
SCHEDULE OF ACTIVITY AND POSITIONS WITH RESPECT TO RSUS AND PSUS

The following table summarizes activity and positions with respect to RSUs and PSUs for the nine months ended September 30, 2023:

 

       Weighted-average 
   Shares   price 
Unvested as of December 31, 2022   8,866,000   $        3.85 
Granted   3,254,000   $4.02 
Vested   (1,374,000)  $7.86 
Forfeited   (423,000)  $8.09 
Unvested as of September 30, 2023   10,323,000   $3.19